CAM
JBIO
Cormorant Asset Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,069,796
| Closed | -$31.6M | – | 52 |
|
|
2024
Q1 | $31.6M | Sell |
1,069,796
-141,900
| -12% | -$4.2M | 1.39% | 22 |
|
|
2023
Q4 | $27.4M | Sell |
1,211,696
-350,000
| -22% | -$7.92M | 1.31% | 22 |
|
|
2023
Q3 | $21.2M | Hold |
1,561,696
| – | – | 1.24% | 22 |
|
|
2023
Q2 | $26.8M | Hold |
1,561,696
| – | – | 1.5% | 19 |
|
|
2023
Q1 | $31.5M | Sell |
1,561,696
-395,436
| -20% | -$7.98M | 2.07% | 14 |
|
|
2022
Q4 | $57.3M | Sell |
1,957,132
-373,559
| -16% | -$10.9M | 3.84% | 6 |
|
|
2022
Q3 | $38.6M | Buy |
2,330,691
+600,000
| +35% | +$9.95M | 2.7% | 10 |
|
|
2022
Q2 | $27.1M | Sell |
1,730,691
-100,000
| -5% | -$1.56M | 2.05% | 16 |
|
|
2022
Q1 | $33.6M | Hold |
1,830,691
| – | – | 2.58% | 13 |
|
|
2021
Q4 | $21.6M | Sell |
1,830,691
-200,000
| -10% | -$2.36M | 1.28% | 24 |
|
|
2021
Q3 | $42M | Hold |
2,030,691
| – | – | 1.71% | 17 |
|
|
2021
Q2 | $44.6M | Buy |
+2,030,691
| New | +$44.6M | 1.52% | 17 |
|